The curious case of the pig liver xenotransplant!
(Source: Journal of Hepatology, 2025)
File under science you did not expect this year.
Surgeons in China stitched a gene edited pig liver next to a man’s own liver. Not a full swap. An auxiliary. Think of it as a helper liver on loan.
For the first month it worked. The graft made bile. It made albumin. It even supplied clotting factors that were pig made yet human active. No lightning fast rejection. No scary allergy storm. The team used a pig with ten gene edits. Three edits remove pig sugars our immune system hates. Seven add human proteins that calm complement and fine tune clotting. Wild.
Then the plot twist. Around week five the patient developed xenotransplantation associated thrombotic microangiopathy. Call it xTMA. Tiny clots in tiny vessels that stress organs. The team removed the pig liver to stop the process, then treated with eculizumab and plasma exchange. The clotting syndrome resolved. Months later the patient died from repeated upper GI bleeding. Total survival after surgery was 171 days.
Why this matters
This is the first living human to run on a pig liver assist and show real metabolic help. It sets a blueprint for using an auxiliary pig liver as a bridge when a tumor or liver failure makes standard surgery impossible. It also flags xTMA as the dragon to watch in future trials.
Weird and wonderful details
The pig liver started dripping golden bile right away and peaked near 400 milliliters a day before settling.
Blood tests picked up pig albumin and pig clotting factors doing real work.
Early biopsies showed no acute rejection. Score one for synthetic biology.
The edited pig carried human proteins like CD46, CD55, CD59, CD39, thrombomodulin, EPCR, and CD47. Yes, a pig expressing human parts to talk our immune system down.
Plain take
Growing spare parts in pigs is no longer sci fi. Hearts and kidneys got the first headlines. Livers are tougher because a liver does everything. Metabolism, detox, immune sorting, clot control. This case shows it can help a human body for meaningful time. It also shows exactly where it can fail and how to respond.
Quick answers
Was this a cure. No. It was a bridge strategy to keep someone alive while the native liver recovered or until another option appeared.
Was there rejection. Not early. The edits plus immunosuppression kept the classic rejection storm away.
What went wrong. A clotting storm unique to cross species transplants. The fix was to remove the graft and block complement.
What is next. Trials that use similar edits, tighter clot control, and clear stop rules. The goal is safe bridging for people with no human donor in time.
If you made it this far you just learned more about pig to human liver science than most dinner tables.
Please do not try to grow a liver in your backyard. (But if you do, send me the video!) ;)
************************************************************************************************
Speaking of Organs, check out this interview I did with a scientist who is working on PRINTING organs!
Want to hear science straight from the researchers mouth? Don’t forget to check out my podcast CAUSES OR CURES, and Subscribe!
Don’t miss interviews, anecdotes, deals and more: Subscribe to my Newsletter!